Table 3.
Multivariate analysis for the association between vitamin D and hepatic steatosis.
| Vitamin D | Age, Sex Adjusted | Multivariate Model I | Multivariate Model II | |||
|---|---|---|---|---|---|---|
| OR (95% CI) | p-Value | OR (95% CI) | p-Value | OR (95% CI) | p-Value | |
| ≥20 (vs. <20 ng/mL) | 0.72 (0.57–0.91) | 0.007 | 0.79 (0.60–1.00) | 0.051 | 0.78 (0.60–1.02) | 0.069 |
| Quartile | ||||||
| 1st (–14.6) | 1 (reference) | 0.006 * | 1 (reference) | 0.037 * | 1 (reference) | 0.065 * |
| 2nd (14.7–19.5) | 0.73 (0.52–1.02) | 0.062 | 0.70 (0.49–0.99) | 0.046 | 0.68 (0.47–1.00) | 0.049 |
| 3rd (19.6–26.7) | 0.62 (0.45–0.87) | 0.005 | 0.66 (0.46–0.95) | 0.024 | 0.65 (0.44–0.94) | 0.022 |
| 4th (26.8–) | 0.57 (0.41–0.80) | 0.001 | 0.61 (0.43–0.87) | 0.007 | 0.64 (0.44–0.94) | 0.021 |
CI, confidence interval; OR, odds ratio; Model I: Adjusted for age, sex, hypertension, diabetes, hypercholesterolemia and body mass index. Model II: Model I plus high-density lipoprotein cholesterol, triglyceride and smoking. * p for trends.